Institutional Ownership Corbus Pharmaceuticals Holdings, Inc. (CRBP)
This table provides information about the institutional ownership of Corbus Pharmaceuticals Holdings, Inc. (CRBP). We have compiled data on the 4 institutions that hold shares in the stock, with a total of 38,662 shares, which have been reported (via 13F filing form) to have a value of $377,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Kingsbury Capital Investment Advisors LLC
Evanston, IL |
Nov 10, 2022 Q3 2022 |
33,700
shares
|
$329,249
0.01% of portfolio
|
Q3 2022
New holding
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
2,650
shares
|
$25,890
0.0% of portfolio
|
Q2 2022
Reduced 44.4%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
2,312
shares
|
$22,588
0.0% of portfolio
|
Q1 2020
Added 21.63%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|